J.P. Morgan Private Wealth Advisors LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 221 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$202,889
-19.0%
4,040
+1.9%
0.00%0.0%
Q2 2023$250,462
+18.3%
3,963
-18.0%
0.00%
Q4 2022$211,646
-33.9%
4,831
-0.6%
0.00%
-100.0%
Q3 2022$320,000
+28.0%
4,858
-1.7%
0.00%0.0%
Q2 2022$250,000
-22.1%
4,941
-1.8%
0.00%0.0%
Q1 2022$321,000
-39.8%
5,031
+1.2%
0.00%0.0%
Q4 2021$533,000
+4.3%
4,9730.0%0.00%0.0%
Q3 2021$511,000
+16.9%
4,973
+0.1%
0.00%0.0%
Q2 2021$437,000
-9.3%
4,967
+0.1%
0.00%
-50.0%
Q1 2021$482,000
-17.5%
4,961
-4.8%
0.00%0.0%
Q4 2020$584,000
+21.9%
5,209
+0.8%
0.00%0.0%
Q3 2020$479,000
+50.2%
5,168
+26.3%
0.00%
+100.0%
Q2 2020$319,000
+33.5%
4,0920.0%0.00%0.0%
Q1 2020$239,000
-27.4%
4,092
-0.2%
0.00%0.0%
Q4 2019$329,000
+9.3%
4,102
+0.2%
0.00%
-50.0%
Q3 2019$301,000
-22.0%
4,0920.0%0.00%0.0%
Q2 2019$386,000
-20.9%
4,092
-32.8%
0.00%
-33.3%
Q1 2019$488,000
+128.0%
6,092
+53.3%
0.00%
+200.0%
Q4 2018$214,000
-34.8%
3,973
-5.4%
0.00%
-50.0%
Q3 2018$328,000
+29.1%
4,202
+4.9%
0.00%
+100.0%
Q2 2018$254,000
-30.8%
4,0050.0%0.00%
-50.0%
Q1 2018$367,000
+21.5%
4,0050.0%0.00%0.0%
Q4 2017$302,000
+3.1%
4,005
-4.7%
0.00%0.0%
Q3 2017$293,0004,2010.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders